Meso Numismatics, Inc. Appoints David Christensen as Director and President
November 29, 2019 at 03:06 pm EST
Share
On November 27, 2019, and in connection with the execution of the Assignment and the LOI, Meso Numismatics, Inc.'s Board of Directors appointed Mr. David Christensen former director and CEO of LAHO, to serve as director and president of the company and, as an inducement, issued to Mr. Christensen 50,000 shares of its Series AA in connection with said appointments. Mr. Christensen has over 25 years' experience in strategy deployment including unique expertise in global supply chains, Point Of Sale, logistics, freight, distributions, inventories, service repairs, CRM, customer service and call center work.
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.
REGENERATIVE MEDICAL TECHNOLOGY GROUP INC. 
